Aclaris Therapeutics, Inc.

ACRS - Company ID 0001557746

Market cap-

Rank-

Filings852

Aclaris Therapeutics, Inc. has filed 852 public company documents between 2012 and 2026. The most frequent type is insider trade (370 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.

Continue researchACRS overviewCompany snapshotMarket cap, financials, charts, and latest company context.

Continue researchMarket cap historyLive rankingSee the market value trend behind the filing history.

Continue researchRevenue trendAnnual historyMove from documents into filing-backed operating results.

Continue researchCompare with LLYPeer viewPut ACRS beside LLY across market cap, revenue, income, and filings.

Browse latest filings across all companies →Follow ACRS via RSS

Similar companies to research next

LLYEli Lilly and Company

Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.

Type	Filing	Filed	Period covered	Open
ARS	Annual report to shareholders	2mo ago2026-04-23	2025-12-31	View filing
ARS	Annual report to shareholders	1y ago2025-04-24	2024-12-31	View filing
ARS	Annual report to shareholders	2y ago2024-04-25	2023-12-31	View filing
ARS	Annual report to shareholders	3y ago2023-04-20	2022-12-31	View filing

Aclaris Therapeutics, Inc.

Similar companies to research next

Year